99 related articles for article (PubMed ID: 16113589)
1. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
Vieira JM; Rodrigues LT; Mantovani E; Dellê H; Mattar AL; Malheiros DM; Noronha IL; Fujihara CK; Zatz R
Nephron Physiol; 2005; 101(4):p82-91. PubMed ID: 16113589
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
5. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.
Blasi ER; Rocha R; Rudolph AE; Blomme EA; Polly ML; McMahon EG
Kidney Int; 2003 May; 63(5):1791-800. PubMed ID: 12675855
[TBL] [Abstract][Full Text] [Related]
7. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
[TBL] [Abstract][Full Text] [Related]
8. MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide synthase inhibitor. Involvement in macrophage and monocyte recruitment.
Kashiwagi M; Masutani K; Shinozaki M; Hirakata H
Nephron; 2002 Sep; 92(1):165-73. PubMed ID: 12187099
[TBL] [Abstract][Full Text] [Related]
9. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
10. The effect of simvastatin and erythropoietin on renal fibrosis in rats with unilateral ureteral obstruction.
Acikgoz Y; Can B; Bek K; Acikgoz A; Ozkaya O; Genç G; Sarikaya S
Ren Fail; 2014 Mar; 36(2):252-7. PubMed ID: 24083846
[TBL] [Abstract][Full Text] [Related]
11. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.
Zhou MS; Schuman IH; Jaimes EA; Raij L
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F53-9. PubMed ID: 18463318
[TBL] [Abstract][Full Text] [Related]
12. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
Motawi TM; Atta HM; Sadik NA; Azzam M
Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
[TBL] [Abstract][Full Text] [Related]
14. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.
Ito K; Chen J; Seshan SV; Khodadadian JJ; Gallagher R; El Chaar M; Vaughan ED; Poppas DP; Felsen D
Kidney Int; 2005 Aug; 68(2):515-28. PubMed ID: 16014028
[TBL] [Abstract][Full Text] [Related]
15. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
Koyanagi M; Egashira K; Kitamoto S; Ni W; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
Circulation; 2000 Oct; 102(18):2243-8. PubMed ID: 11056100
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
18. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
Ono H; Saitoh M; Ono Y; Ishimitu T; Matsuoka H
J Hypertens; 2004 Jul; 22(7):1389-95. PubMed ID: 15201556
[TBL] [Abstract][Full Text] [Related]
19. Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury.
Fujihara CK; Sena CR; Malheiros DM; Mattar AL; Zatz R
Am J Physiol Renal Physiol; 2006 Mar; 290(3):F632-40. PubMed ID: 16204410
[TBL] [Abstract][Full Text] [Related]
20. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
